New trial tests faster radiation for men with spread prostate cancer
NCT ID NCT04610372
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares standard moderate radiation (4 weeks) with shorter, more intense radiation schedules (1-2 weeks or a single session) for treating the prostate in men whose cancer has spread to a few other spots (oligometastatic). The goal is to see if the shorter treatments are as well-tolerated and effective, while being more convenient and cost-effective. About 168 men who have not had prior prostate cancer treatment (except hormone therapy) will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiation therapy (hypofractionated external beam radiotherapy, high dose rate brachytherapy, permanent seed implant, or stereotactic body radiotherapy)
What this could lead to
If successful, this could offer men with oligometastatic prostate cancer a more convenient and cost-effective radiation option with similar safety and quality of life.
What could go wrong
This is a Phase 2 trial with only 168 participants, so results may not apply to everyone. The shorter radiation schedules could have different side effects or be less effective in the long run.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
British Columbia Cancer Agency Center for the Southern Interior
RECRUITINGKelowna, British Columbia, V1Y5L3, Canada
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Fraser Valley Cancer Center
NOT_YET_RECRUITINGSurrey, British Columbia, Canada
Contact Email: •••••@•••••
-
Vancouver Cancer Center
RECRUITINGVancouver, British Columbia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vancouver Island Cancer Center
RECRUITINGVictoria, British Columbia, Canada
Contact
Contact
Contact
Contact
Contact Email: •••••@•••••